აუტოიმუნური ჰეპატიტი

Mack CL, Adams D, Assis DN, et al. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases. Hepatology. 2020 Aug;72(2):671-722.სრული ტექსტი  აბსტრაქტი

European Association for the Study of the Liver. EASL clinical practice guidelines: autoimmune hepatitis. J Hepatol. 2015 Oct;63(4):971-1004. აბსტრაქტი

Gleeson D, Heneghan MA; British Society of Gastroenterology. British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis. Gut. 2011 Dec;60(12):1611-29.სრული ტექსტი  აბსტრაქტი

Strassburg CP, Manns MP. Treatment of autoimmune hepatitis. Semin Liver Dis. 2009 Aug;29(3):273-85. აბსტრაქტი

Selvarajah V, Montano-Loza AJ, Czaja AJ. Systematic review: managing suboptimal treatment responses in autoimmune hepatitis with conventional and nonstandard drugs. Aliment Pharmacol Ther. 2012 Oct;36(8):691-707.სრული ტექსტი  აბსტრაქტი

1. Mack CL, Adams D, Assis DN, et al. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases. Hepatology. 2020 Aug;72(2):671-722.სრული ტექსტი  აბსტრაქტი

2. Zachou K, Rigopoulou E, Dalekos GN. Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease. J Autoimmune Dis. 2004 Oct 15;1(1):2.სრული ტექსტი  აბსტრაქტი

3. Krawitt EL. Autoimmune hepatitis. N Engl J Med. 2006 Jan 5;354(1):54-66. აბსტრაქტი

4. Lv T, Li M, Zeng N, et al. Systematic review and meta-analysis on the incidence and prevalence of autoimmune hepatitis in Asian, European, and American population. J Gastroenterol Hepatol. 2019 Oct;34(10):1676-84. აბსტრაქტი

5. Grønbæk L, Vilstrup H, Jepsen P. Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study. J Hepatol. 2014 Mar;60(3):612-7. აბსტრაქტი

6. Ngu JH, Bechly K, Chapman BA, et al. Population-based epidemiology study of autoimmune hepatitis: a disease of older women? J Gastroenterol Hepatol. 2010 Oct;25(10):1681-6. აბსტრაქტი

7. van Gerven NM, Verwer BJ, Witte BI, et al. Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands. Scand J Gastroenterol. 2014 Oct;49(10):1245-54. აბსტრაქტი

8. Radhakrishnan KR, Alkhouri N, Worley S, et al. Autoimmune hepatitis in children--impact of cirrhosis at presentation on natural history and long-term outcome. Dig Liver Dis. 2010 Oct;42(10):724-8. აბსტრაქტი

9. Deneau M, Jensen MK, Holmen J, et al. Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children: epidemiology and natural history. Hepatology. 2013 Oct;58(4):1392-400.სრული ტექსტი  აბსტრაქტი

10. Jiménez-Rivera C, Ling SC, Ahmed N, et al. Incidence and characteristics of autoimmune hepatitis. Pediatrics. 2015 Nov;136(5):e1237-48. აბსტრაქტი

11. Trivedi PJ, Hirschfield GM. Recent advances in clinical practice: epidemiology of autoimmune liver diseases. Gut. 2021 Oct;70(10):1989-2003. აბსტრაქტი

12. Moy L, Levine J. Autoimmune hepatitis: a classic autoimmune liver disease. Curr Probl Pediatr Adolesc Health Care. 2014 Dec;44(11):341-6. აბსტრაქტი

13. Czaja AJ. Autoimmune hepatitis: approach to diagnosis. MedGenMed. 2006 May 23;8(2):55.სრული ტექსტი  აბსტრაქტი

14. Mieli-Vergani G, Vergani D, Czaja AJ, et al. Autoimmune hepatitis. Nat Rev Dis Primers. 2018 Apr 12;4:18017. აბსტრაქტი

15. Czaja AJ. Autoimmune liver disease. Curr Opin Gastroenterol. 2006 May;22(3):234-40. აბსტრაქტი

16. Jenkins A, Austin A, Hughes K, et al. Infliximab-induced autoimmune hepatitis. BMJ Case Rep. 2021 May 24;14(5):e239944. აბსტრაქტი

17. Franco DL, Kale S, Lam-Himlin DM, et al. Black cohosh hepatotoxicity with autoimmune hepatitis presentation. Case Rep Gastroenterol. 2017 Jan-Apr;11(1):23-8.სრული ტექსტი  აბსტრაქტი

18. Manns MP, Vogel A. Autoimmune hepatitis, from mechanisms to therapy. Hepatology. 2006 Feb;43(2 Suppl 1):S132-44. აბსტრაქტი

19. Webb GJ, Hirschfield GM, Krawitt EL, et al. Cellular and molecular mechanisms of autoimmune hepatitis. Annu Rev Pathol. 2018 Jan 24;13:247-92.სრული ტექსტი  აბსტრაქტი

20. Wang Q, Yang F, Miao Q, et al. The clinical phenotypes of autoimmune hepatitis: a comprehensive review. J Autoimmun. 2016 Jan;66:98-107. აბსტრაქტი

21. Potts JR, Verma S. Optimizing management in autoimmune hepatitis with liver failure at initial presentation. World J Gastroenterol. 2011 Apr 28;17(16):2070-5.სრული ტექსტი  აბსტრაქტი

22. Braga AC, Vasconcelos C, Braga J. Pregnancy with autoimmune hepatitis. Gastroenterol Hepatol Bed Bench. 2016 Summer;9(3):220-4.სრული ტექსტი  აბსტრაქტი

23. Al-Chalabi T, Underhill JA, Portmann BC, et al. Effects of serum aspartate aminotransferase levels in patients with autoimmune hepatitis influence disease course and outcome. Clin Gastroenterol Hepatol. 2008 Dec;6(12):1389-95.სრული ტექსტი  აბსტრაქტი

24. Komori A. Recent updates on the management of autoimmune hepatitis. Clin Mol Hepatol. 2021 Jan;27(1):58-69.სრული ტექსტი  აბსტრაქტი

25. Yang F, Wang Q, Bian Z, et al. Autoimmune hepatitis: east meets west. J Gastroenterol Hepatol. 2015 Aug;30(8):1230-6.სრული ტექსტი  აბსტრაქტი

26. European Association for the Study of the Liver. EASL clinical practice guidelines: autoimmune hepatitis. J Hepatol. 2015 Oct;63(4):971-1004. აბსტრაქტი

27. Sebode M, Weiler-Normann C, Liwinski T, et al. Autoantibodies in autoimmune liver disease-clinical and diagnostic relevance. Front Immunol. 2018 Mar 27;9:609.სრული ტექსტი  აბსტრაქტი

28. Zeman MV, Hirschfield GM. Autoantibodies and liver disease: uses and abuses. Can J Gastroenterol. 2010 Apr;24(4):225-31.სრული ტექსტი  აბსტრაქტი

29. Manns MP. Antibodies to soluble liver antigen: specific marker of autoimmune hepatitis. J Hepatol. 2000 Aug;33(2):326-8.სრული ტექსტი  აბსტრაქტი

30. Expert Panel on Gastrointestinal Imaging, Arif-Tiwari H, Porter KK, et al. ACR appropriateness criteria® abnormal liver function tests. J Am Coll Radiol. 2023 Nov;20(11s):S302-14.სრული ტექსტი  აბსტრაქტი

31. Dong Y, Potthoff A, Klinger C, et al. Ultrasound findings in autoimmune hepatitis. World J Gastroenterol. 2018 Apr 21;24(15):1583-90.სრული ტექსტი  აბსტრაქტი

32. Sue MJ, Lee EW, Saab S, et al. Transjugular liver biopsy: safe even in patients with severe coagulopathies and multiple biopsies. Clin Transl Gastroenterol. 2019 Jul;10(7):e00063.სრული ტექსტი  აბსტრაქტი

33. Thomaides-Brears HB, Alkhouri N, Allende D, et al. Incidence of complications from percutaneous biopsy in chronic liver disease: a systematic review and meta-analysis. Dig Dis Sci. 2022 Jul;67(7):3366-94.სრული ტექსტი  აბსტრაქტი

34. Tiniakos DG, Brain JG, Bury YA. Role of histopathology in autoimmune hepatitis. Dig Dis. 2015;33 Suppl 2:53-64.სრული ტექსტი  აბსტრაქტი

35. Welz-Kubiak K, Reszke R, Szepietowski JC. Pruritus as a sign of systemic disease. Clin Dermatol. 2019 Nov-Dec;37(6):644-56. აბსტრაქტი

36. Gleeson D, Heneghan MA; British Society of Gastroenterology. British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis. Gut. 2011 Dec;60(12):1611-29.სრული ტექსტი  აბსტრაქტი

37. European Association for the Study of the Liver; Clinical Practice Guideline Panel; Chair, et al. EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update. J Hepatol. 2021 Sep;75(3):659-89.სრული ტექსტი  აბსტრაქტი

38. Tonolini M, Bianco R. HIV-related/AIDS cholangiopathy: pictorial review with emphasis on MRCP findings and differential diagnosis. Clin Imaging. 2013 Mar-Apr;37(2):219-26. აბსტრაქტი

39. Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999 Nov;31(5):929-38. აბსტრაქტი

40. Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008 Jul;48(1):169-76.სრული ტექსტი  აბსტრაქტი

41. Lamers MM, van Oijen MG, Pronk M, et al. Treatment options for autoimmune hepatitis: a systematic review of randomized controlled trials. J Hepatol. 2010 Jul;53(1):191-8.სრული ტექსტი  აბსტრაქტი

42. Yeoman AD, Longhi MS, Heneghan MA. Review article: the modern management of autoimmune hepatitis. Aliment Pharmacol Ther. 2010 Apr;31(8):771-87.სრული ტექსტი  აბსტრაქტი

43. Zandieh I, Krygier D, Wong V, et al. The use of budesonide in the treatment of autoimmune hepatitis in Canada. Can J Gastroenterol. 2008 Apr;22(4):388-92.სრული ტექსტი  აბსტრაქტი

44. Wiegand J, Schüler A, Kanzler S, et al. Budesonide in previously untreated autoimmune hepatitis. Liver Int. 2005 Oct;25(5):927-34. აბსტრაქტი

45. Strassburg CP, Manns MP. Treatment of autoimmune hepatitis. Semin Liver Dis. 2009 Aug;29(3):273-85. აბსტრაქტი

46. Manns MP, Woynarowski M, Kreisel W, et al. Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis. Gastroenterology. 2010 Oct;139(4):1198-206. აბსტრაქტი

47. Csepregi A, Röcken C, Treiber G, et al. Budesonide induces complete remission in autoimmune hepatitis. World J Gastroenterol. 2006 Mar 7;12(9):1362-6. აბსტრაქტი

48. Woynarowski M, Nemeth A, Baruch Y, et al; European Autoimmune Hepatitis-Budesonide Study Group. Budesonide versus prednisone with azathioprine for the treatment of autoimmune hepatitis in children and adolescents. J Pediatr. 2013 Nov;163(5):1347-53.e1. აბსტრაქტი

49. Yu ZJ, Zhang LL, Huang TT, et al. Comparison of mycophenolate mofetil with standard treatment for autoimmune hepatitis: a meta-analysis. Eur J Gastroenterol Hepatol. 2019 Jul;31(7):873-7. აბსტრაქტი

50. Selvarajah V, Montano-Loza AJ, Czaja AJ. Systematic review: managing suboptimal treatment responses in autoimmune hepatitis with conventional and nonstandard drugs. Aliment Pharmacol Ther. 2012 Oct;36(8):691-707.სრული ტექსტი  აბსტრაქტი

51. Nasseri-Moghaddam S, Nikfam S, Karimian S, et al. Cyclosporine-A versus prednisolone for induction of remission in auto-immune hepatitis: interim analysis report of a randomized controlled trial. Middle East J Dig Dis. 2013 Oct;5(4):193-200.სრული ტექსტი  აბსტრაქტი

52. Malekzadeh R, Nasseri-Moghaddam S, Kaviani MJ, et al. Cyclosporin A is a promising alternative to corticosteroids in autoimmune hepatitis. Dig Dis Sci. 2001 Jun;46(6):1321-7. აბსტრაქტი

53. Carbone M, Neuberger JM. Autoimmune liver disease, autoimmunity and liver transplantation. J Hepatol. 2014 Jan;60(1):210-23.სრული ტექსტი  აბსტრაქტი

54. Molmenti EP, Netto GJ, Murray NG, et al. Incidence and recurrence of autoimmune/alloimmune hepatitis in liver transplant recipients. Liver Transpl. 2002 Jun;8(6):519-26.სრული ტექსტი  აბსტრაქტი

55. Chatrath H, Allen L, Boyer TD. Use of sirolimus in the treatment of refractory autoimmune hepatitis. Am J Med. 2014 Nov;127(11):1128-31. აბსტრაქტი

56. D'Agostino D, Costaguta A, Álvarez F. Successful treatment of refractory autoimmune hepatitis with rituximab. Pediatrics. 2013 Aug;132(2):e526-30. აბსტრაქტი

57. Weiler-Normann C, Schramm C, Quaas A, et al. Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis. J Hepatol. 2013 Mar;58(3):529-34. აბსტრაქტი

58. Wong F, Al Ibrahim B, Walsh J, et al. Infliximab-induced autoimmune hepatitis requiring liver transplantation. Clin Case Rep. 2019 Sep 27;7(11):2135-9.სრული ტექსტი  აბსტრაქტი

59. Karanfilian B, Mahpour N, Sarkar A. Infliximab drug-induced autoimmune hepatitis in a patient with Crohn's ileocolitis. Am J Ther. 2020 Dec 29 [Epub ahead of print]. აბსტრაქტი

60. Czaja AJ, Carpenter HA, Lindor KD. Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: a randomized placebo-controlled treatment trial. Hepatology. 1999 Dec;30(6):1381-6. აბსტრაქტი

61. Joshi S, Cauch-Dudek K, Wanless IR, et al. Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid. Hepatology. 2002 Feb;35(2):409-13.სრული ტექსტი  აბსტრაქტი

62. Squires RH, Ng V, Romero R, et al. Evaluation of the pediatric patient for liver transplantation: 2014 practice guideline by the American Association for the Study of Liver Diseases, American Society of Transplantation and the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition. Hepatology. 2014 Jul;60(1):362-98.სრული ტექსტი  აბსტრაქტი

63. Abhyankar A, Tapper E, Bonder A. Immunosuppressive therapy in immune-mediated liver disease in the non-transplanted patient. Pharmaceuticals (Basel). 2013 Dec 30;7(1):18-28.სრული ტექსტი  აბსტრაქტი

64. Hoeroldt B, McFarlane E, Dube A, et al. Long-term outcomes of patients with autoimmune hepatitis managed at a nontransplant center. Gastroenterology. 2011 Jun;140(7):1980-9.სრული ტექსტი  აბსტრაქტი

65. Czaja AJ. Rapidity of treatment response and outcome in type 1 autoimmune hepatitis. J Hepatol. 2009 Jul;51(1):161-7. აბსტრაქტი

66. Sucher E, Sucher R, Gradistanac T, et al. Autoimmune hepatitis-immunologically triggered liver pathogenesis-diagnostic and therapeutic strategies. J Immunol Res. 2019 Nov 25;2019:9437043.სრული ტექსტი  აბსტრაქტი

67. Czaja AJ. Special clinical challenges in autoimmune hepatitis: the elderly, males, pregnancy, mild disease, fulminant onset, and nonwhite patients. Semin Liver Dis. 2009 Aug;29(3):315-30. აბსტრაქტი

68. Czaja AJ, Carpenter HA. Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly. Hepatology. 2006 Mar;43(3):532-8.სრული ტექსტი  აბსტრაქტი

69. Miyake T, Miyaoka H, Abe M, et al. Clinical characteristics of autoimmune hepatitis in older aged patients. Hepatol Res. 2006 Oct;36(2):139-42. აბსტრაქტი

70. Cross TJ, Antoniades CG, Muiesan P, et al. Liver transplantation in patients over 60 and 65 years: an evaluation of long-term outcomes and survival. Liver Transpl. 2007 Oct;13(10):1382-8.სრული ტექსტი  აბსტრაქტი

71. Al-Chalabi T, Underhill JA, Portmann BC, et al. Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis. J Hepatol. 2008 Jan;48(1):140-7. აბსტრაქტი

72. Sharma R, Simon TG, Stephansson O, et al. Pregnancy outcomes in women with autoimmune hepatitis - a nationwide population-based cohort study with histopathology. Clin Gastroenterol Hepatol. 2023 Jan;21(1):103-14.e10.სრული ტექსტი  აბსტრაქტი

73. Westbrook RH, Yeoman AD, Kriese S, et al. Outcomes of pregnancy in women with autoimmune hepatitis. J Autoimmun. 2012 May;38(2-3):J239-44. აბსტრაქტი

74. Bozward AG, Wootton GE, Podstawka O, et al. Autoimmune hepatitis: tolerogenic immunological state during pregnancy and immune escape in post-partum. Front Immunol. 2020 Sep 24;11:591380.სრული ტექსტი  აბსტრაქტი

75. Francella A, Dyan A, Bodian C, et al. The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. Gastroenterology. 2003 Jan;124(1):9-17.სრული ტექსტი  აბსტრაქტი

76. Natekar A, Pupco A, Bozzo P, et al. Safety of azathioprine use during pregnancy. Can Fam Physician. 2011 Dec;57(12):1401-2.სრული ტექსტი  აბსტრაქტი

77. Akbari M, Shah S, Velayos FS, et al. Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013 Jan;19(1):15-22. აბსტრაქტი

78. Mendizabal M, Marciano S, Videla MG, et al. Fulminant presentation of autoimmune hepatitis: clinical features and early predictors of corticosteroid treatment failure. Eur J Gastroenterol Hepatol. 2015 Jun;27(6):644-8. აბსტრაქტი

79. Montano-Loza AJ, Carpenter HA, Czaja AJ. Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease. Hepatology. 2007 Oct;46(4):1138-45. აბსტრაქტი

80. Schramm C, Wahl I, Weiler-Normann C, et al. Health-related quality of life, depression, and anxiety in patients with autoimmune hepatitis. J Hepatol. 2014 Mar;60(3):618-24. აბსტრაქტი

81. UK Health Security Agency. Hepatitis A: the green book, chapter 17. Jan 2024 [internet publication].სრული ტექსტი